Unknown

Dataset Information

0

Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines.


ABSTRACT: A SARS-like coronavirus 2 (SARS-CoV-2) has caused a pandemic Coronavirus Disease 2019 (COVID-19) that killed more than 3.3 million people worldwide. Like the SARS-CoV, SARS-CoV-2 also employs a receptor-binding motif (RBM) of its spike protein to bind a host receptor, the angiotensin-converting enzyme 2 (ACE2), to gain entry. Currently, several mRNA or adenoviral vaccines encoding for the spike protein of SARS-CoV-2 are being used to boost antibodies capable of inhibiting spike-ACE2 interaction and viral entry. However, recent evidence has also suggested an anti-inflammatory effect of spike-reactive antibodies, suggesting that some SARS-CoV-2 spike-based vaccines may elicit protective antibodies capable of inhibiting GM-CSF production and COVID-19 progression.

SUBMITTER: Li J 

PROVIDER: S-EPMC8140578 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5215529 | biostudies-other
| S-EPMC7480027 | biostudies-literature
| S-EPMC8251270 | biostudies-literature
| S-SCDT-EMM-2021-14844 | biostudies-other
| EMPIAR-10947 | biostudies-other
| S-EPMC6204844 | biostudies-literature
| S-EPMC3145786 | biostudies-literature
| S-EPMC8311925 | biostudies-literature
| S-EPMC8151995 | biostudies-literature
| S-EPMC7827936 | biostudies-literature